Application due dates on or after February 16, 2023 and subsequent receipt dates through January 4, 2024
The purpose of this Notice of Special Interest (NOSI) is to support secondary data analysis to address questions and advance scientific inquiry related to SARS-CoV-2 through the existing data resources in the Rapid Acceleration of Dignostics Data Hub (RADx DataHub), including and in conjunction with other data resources.
Topics: Applied Research, Biomarkers, Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Co-Morbidities, COVID-19, Community Engagement, Computational Analysis, Computational or Data Science Methods Development, Diagnostics, Antibody Detection, Diagnostics Development, Diagnostic Efficacy, Diagnostic Reliability, Diagnostic Scalability, Viral Detection, Economic Impact, Education and Training, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Clinical History, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Surveillance, Transmission, Aerosol, Health Disparities, Healthcare Implementation, Mobile Health, Product Development and Commercialization, Prognostics, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Vaccines, Vaccine Hesitancy, Social Determinants of Health, Treatments, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Drugs, Antibody-based Treatment, Convalescent Serum, Drug Development, Drug Repurposing, Drug Targets, Immunological Response Targets, Anti-viral Targets